Sara E Hertzke-hill, PA-C | |
201 S Ash St, Buffalo, MO 65622 | |
(417) 345-6100 | |
Not Available |
Full Name | Sara E Hertzke-hill |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 201 S Ash St, Buffalo, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790032332 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 2012023814 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sara E Hertzke-hill, PA-C 201 S Ash St, Buffalo, MO 65622-8674 Ph: (417) 345-6100 | Sara E Hertzke-hill, PA-C 201 S Ash St, Buffalo, MO 65622 Ph: (417) 345-6100 |
News Archive
Personalities and politics swirl around news about Monday's ruling in the Virginia health law challenge, with news outlets detailing how judges in different cases reached their conclusions and examining Judge Henry Hudson's ties to a GOP consulting firm. More reports also surround the related political dust-ups and posturing.
VTT Technical Research Centre of Finland has developed a mobile phone-based navigation service which guides older users to the right address, even when lost in a strange town. The result of a European project, the service helps older people to use public transport, assisting them along the entire route.
A future weapon in the battle against obesity and diabetes could come in the form of an oil derived from the seeds of wild almond trees, according to researchers at Missouri University of Science and Technology.
Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its second quarter 2011 results.
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER.
› Verified 4 days ago